Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

Overview of attention for article published in Cardiovascular Diabetology, October 2021

Altmetric Badge

Mentioned by

twitter: 1 tweeter

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Impact of SGLT2 Inhibitor Therapy on Right Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction

Article in Journal of Clinical Medicine (December 2022)

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Article in Circulation (November 2022)

Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review

Article in Cureus (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.